Pediatric Nonalcoholic Fatty Liver Disease: Current Thinking.

Area of Science:

• Pediatric Gastroenterology
• Hepatology
• Internal Medicine

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a growing concern in children.
• Diagnosis and management involve pediatric gastroenterologists, hepatologists, and general pediatricians.

Purpose of the Study:

• To update recent advances in the diagnosis and treatment of pediatric NAFLD for practical application.
• To highlight the importance of early risk assessment for cirrhosis in childhood.

Main Methods:

• Diagnosis relies on risk factor assessment and exclusion of other conditions.
• Transient elastography and biomarkers are being explored but require further validation in pediatric populations.

Main Results:

• Risk stratification for cirrhosis involves a combination of genetic, clinical, and environmental factors.
• Weight reduction is the primary treatment, but compliance is a challenge.

Conclusions:

• Further validation of diagnostic techniques like elastography and biomarkers is needed for pediatric NAFLD.
• While some pharmacological options like docosahexaenoic acid, probiotics, and vitamin E are considered, evidence for widespread use is insufficient.